The differential loss of [ 3H]pirenzepine [formula omitted] [ 3H](−)Quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor

[ 3H]Pirenzepine ([ 3H]PZ) and [ 3H](−)Quinuclidinylbenzilate ([ 3H](−)QNB) specific binding to soluble rat brain muscarinic cholinergic receptors was assessed as a function of time subsequent to receptor solubilization. The soluble brain muscarinic receptor is stable at 4°C when assayed by [ 3H](−)...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 118; no. 3; pp. 950 - 957
Main Authors Roeske, William R., Venter, J.Craig
Format Journal Article
LanguageEnglish
Published Elsevier Inc 1984
Online AccessGet full text

Cover

Loading…
More Information
Summary:[ 3H]Pirenzepine ([ 3H]PZ) and [ 3H](−)Quinuclidinylbenzilate ([ 3H](−)QNB) specific binding to soluble rat brain muscarinic cholinergic receptors was assessed as a function of time subsequent to receptor solubilization. The soluble brain muscarinic receptor is stable at 4°C when assayed by [ 3H](−)QNB binding ( t 1 2 = 80 hrs ). In contrast the pirenzepine state of the receptor decays rapidly ( t 1 2 = 3.0 hrs ). Prior occupation of the receptor with [ 3H](−)QNB or [ 3H]PZ increases the receptor stability by two to five fold ( t 1 2 QNB >1,000 hrs ; t 1 2 PZ = 6.5 hrs ). These data indicate that pirenzepine binds to an allosteric state of the muscarinic receptor and that caution should be employed in the assignment of receptor subtypes based solely upon the binding of ligands which recognize unique conformational states.
ISSN:0006-291X
1090-2104
DOI:10.1016/0006-291X(84)91487-6